![](/img/cover-not-exists.png)
The impact of the 21-gene recurrence score assay on decision making about adjuvant chemotherapy in early-stage estrogen-receptor-positive breast cancer in an oncology practice with a unified treatment policy
Geffen, D. B., Abu-Ghanem, S., Sion-Vardy, N., Braunstein, R., Tokar, M., Ariad, S., Delgado, B., Bayme, M., Koretz, M.Volume:
22
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdq769
Date:
November, 2011
File:
PDF, 224 KB
english, 2011